Literature DB >> 11466136

Hormone replacement therapy shortens QT dispersion in healthy postmenopausal women.

A Yildirir1, F Aybar, M G Kabakci, H Yarali, E Akgul, O Bukulmez, S L Tokgozoglu, T Gurgan, A Oto.   

Abstract

BACKGROUND: The aim of the study was to investigate the effects of hormone replacement therapy (HRT) on myocardial repolarization characteristics in postmenopausal women without coronary artery disease.
METHODS: Fifty-one consecutive healthy postmenopausal women (age 48 +/- 5) with negative exercise stress testing were prospectively enrolled into the study. Standard 12-lead electrocardiograms were obtained to evaluate the effects of 6 months of HRT on QT intervals, corrected QT intervals (QTcmax and QTcmin), QT dispersion (QTd), and corrected QTd (QTcd). Hormone regimens were continuous 0.625 mg/day conjugated equine estrogen (CEE) plus 2.5 mg/day medroxyprogesterone acetate (MPA) or 0.625 mg/day CEE alone depending on the hysterectomy status.
RESULTS: Although not statistically significant, CEE alone or in combination with MPA increased QTmax and QTmin values. However, the increase in QTmin was greater than the increase in QTmax, which resulted in statistically significant shortening of QTd (P = 0.007 in CEE and P < 0.001 in CEE + MPA groups). There was a significant prolongation of QTcmin values after 6 months in patients assigned to the CEE group (P = 0.001). The QTcd values were significantly shortened by HRT with both regimens (for CEE group 49 +/- 13 ms vs 38 +/- 13 ms, P = 0.01; for CEE + MPA group 49 +/- 14 ms vs 36 +/- 13, P < 0.001).
CONCLUSION: HRT significantly decreased the QTd and QTcd in postmenopausal women without coronary artery disease, independent of the addition of MPA to the regimen. This improvement in myocardial repolarization may be one of the mechanisms of the favorable effects of HRT on cardiovascular system. However, the clinical implications of the shortening of QTd in postmenopausal women with HRT must be clarified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466136      PMCID: PMC7027636          DOI: 10.1111/j.1542-474x.2001.tb00107.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  16 in total

Review 1.  Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A review.

Authors:  S D Kafonek
Journal:  Drugs       Date:  1994       Impact factor: 9.546

2.  Effects of hormone replacement therapy on QT interval.

Authors:  J A Larsen; R H Tung; R Sadananda; J J Goldberger; G Horvath; M A Parker; A H Kadish
Journal:  Am J Cardiol       Date:  1998-10-15       Impact factor: 2.778

3.  Postmenopausal hormone therapy and mortality.

Authors:  F Grodstein; M J Stampfer; G A Colditz; W C Willett; J E Manson; M Joffe; B Rosner; C Fuchs; S E Hankinson; D J Hunter; C H Hennekens; F E Speizer
Journal:  N Engl J Med       Date:  1997-06-19       Impact factor: 91.245

4.  Sex difference in risk of torsade de pointes with d,l-sotalol.

Authors:  M H Lehmann; S Hardy; D Archibald; B quart; D J MacNeil
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

Review 5.  Steroid hormones and the cardiovascular system: direct actions of estradiol, progesterone, testosterone, gluco- and mineralcorticoids, and soltriol [vitamin D] on central nervous regulatory and peripheral tissues.

Authors:  W E Stumpf
Journal:  Experientia       Date:  1990-01-15

6.  Effect of estrogen on ventricular repolarization in menopausal patients with syndrome X and effects of nicorandil.

Authors:  T M Lee; S F Su; Y T Lee; C H Tsai
Journal:  Am J Cardiol       Date:  1999-07-01       Impact factor: 2.778

7.  Circadian variations of QTc dispersion: is it a clue to morning increase of sudden cardiac death?

Authors:  M K Batur; S Aksöyek; A Oto; A Yildirir; N Ozer; E Atalar; K Aytemir; G Kabakci; K Ovünç; F Ozmen; S Kes
Journal:  Clin Cardiol       Date:  1999-02       Impact factor: 2.882

8.  Absence of effects of short-term estrogen replacement therapy on resting and exertional QT and QTc dispersion in postmenopausal women with coronary artery disease.

Authors:  E Sbarouni; E Zarvalis; Z S Kyriakides; D T Kremastinos
Journal:  Pacing Clin Electrophysiol       Date:  1998-11       Impact factor: 1.976

9.  Estrogen modulates responses of atherosclerotic coronary arteries.

Authors:  J K Williams; M R Adams; H S Klopfenstein
Journal:  Circulation       Date:  1990-05       Impact factor: 29.690

Review 10.  The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women.

Authors:  F Grodstein; M Stampfer
Journal:  Prog Cardiovasc Dis       Date:  1995 Nov-Dec       Impact factor: 8.194

View more
  2 in total

1.  Estrogen contributes to gender differences in mouse ventricular repolarization.

Authors:  Tomoaki Saito; Andrea Ciobotaru; Jean Chrisostome Bopassa; Ligia Toro; Enrico Stefani; Mansoureh Eghbali
Journal:  Circ Res       Date:  2009-07-16       Impact factor: 17.367

Review 2.  Sexual Dimorphisms, Anti-Hormonal Therapy and Cardiac Arrhythmias.

Authors:  Virginie Grouthier; Melissa Y Y Moey; Estelle Gandjbakhch; Xavier Waintraub; Christian Funck-Brentano; Anne Bachelot; Joe-Elie Salem
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.